Metabolic alteration of neuroactive steroids and protective effect of progesterone in Alzheimer's disease-like rats

Neural Regeneration Research

Volumn 8, Issue 30, 2013, Pages 2800-2810

  Liu, Sha ^a   Wu, Hong Hai ^b   Xue, Gai ^b   Ma, Xin ^a   Wu, Jie ^a   Qin, Ya Bin ^a   Hou, Yan Ning ^a,b  

^a HEBEI MEDICAL UNIVERSITY   (China)

^b BETHUNE INTERNATIONAL PEACE HOSPITAL   (China)

Author keywords

Alzheimer's disease; Amyloid beta; Cognition; Neural regeneration; Neuroactive steroids; Neurodegenerative disease; Neuroprotection; Neuroregeneration; Proge sterone

Indexed keywords

3ALPHA HYDROXY 5ALPHA PREGNAN 20 ONE; AMYLOID BETA PROTEIN [25-35]; ESTRADIOL; INTERLEUKIN 1BETA; METHYLTESTOSTERONE; PREGNENOLONE; PROGESTERONE; STEROID; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; NEUROACTIVE STEROID;

ALZHEIMER DISEASE; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COGNITIVE DEFECT; CONTROLLED STUDY; GENE EXPRESSION; HIPPOCAMPAL CA1 REGION; HISTOLOGY; MALE; MAZE TEST; NEUROPROTECTION; NONHUMAN; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SPATIAL LEARNING; SURVIVAL RATE; TASK PERFORMANCE; UPREGULATION; WESTERN BLOTTING; BEHAVIOR DISORDER; CELL LOSS; COGNITION ASSESSMENT; CYTOKINE PRODUCTION; DRUG MEGADOSE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; LEARNING AND MEMORY TEST; LOW DRUG DOSE; MASS SPECTROMETRY; MEMORY; MEMORY DISORDER; METABOLISM; MORRIS WATER MAZE TEST; POLYACRYLAMIDE GEL ELECTROPHORESIS; PREFRONTAL CORTEX;

EID: 84889016965     PISSN: 16735374     EISSN: 18767958     Source Type: Journal    
DOI: 10.3969/j.issn.1673-5374.2013.30.002     Document Type: Article

References (57)

1. Khairallah MI, Kassem LA. Alzheimer's disease: current status of etiopathogenesis and therapeutic strategies. Pak J Biol Sci. 2011;14(4):257-272.
2. Selkoe DJ. Translating cell biology into therapeutic ad-vances in Alzheimer's disease. Nature. 1999;399(6738 Suppl):A23-31.
3. Haass C, Selkoe DJ. Soluble protein oligomers in neuro-degeneration: lessons from the Alzheimer's amyloid be-ta-peptide. Nat Rev Mol Cell Biol. 2007;8(2):101-112.
4. Ekinci FJ, Linsley MD, Shea TB. Beta-amyloid-induced calcium influx induces apoptosis in culture by oxidative stress rather than tau phosphorylation. Brain Res Mol Brain Res. 2000;76(2):389-395.
5. Geula C, Wu CK, Saroff D, et al. Aging renders the brain vulnerable to amyloid beta-protein neurotoxicity. Nat Med. 1998;4(7):827-831.
6. Hardy J, Selkoe DJ. The amyloid hypothesis of Alzhei-mer's disease: progress and problems on the road to therapeutics. Science. 2002;297(5580):353-356.
7. Abramov AY, Duchen MR. The role of an astrocytic NADPH oxidase in the neurotoxicity of amyloid beta pep-tides. Philos Trans R Soc Lond B Biol Sci. 2005; 360(1464):2309-2314.
8. Zhang J, Zhen YF, Pu-Bu-Ci-Ren, et al. Salidroside atte-nuates beta amyloid-induced cognitive deficits via mod-ulating oxidative stress and inflammatory mediators in rat hippocampus. Behav Brain Res. 2013;244:70-81.
9. Zussy C, Brureau A, Keller E, et al. Alzheimer's disease related markers, cellular toxicity and behavioral deficits induced six weeks after oligomeric amyloid-β peptide in-jection in rats. PLoS One. 2013;8(1):e53117.
10. Richardson JS, Zhou Y, Kumar U. Free radicals in the neurotoxic actions of beta-amyloid. Ann N Y Acad Sci. 1996;777:362-367.
11. Baulieu EE. Neurosteroids: a new function in the brain. Biol Cell. 1991;71(1-2):3-10.
12. Mellon SH, Griffin LD. Neurosteroids: biochemistry and clinical significance. Trends Endocrinol Metab. 2002;13(1): 35-43.
13. Corpéchot C, Synguelakis M, Talha S, et al. Pregnenolone and its sulfate ester in the rat brain. Brain Res. 1983;270(1):119-125.
14. Carta MG, Bhat KM, Preti A. GABAergic neuroactive ste-roids: a new frontier in bipolar disorders? Behav Brain Funct. 2012;8:61.
15. Belelli D, Lambert JJ. Neurosteroids: endogenous regu-lators of the GABA(A) receptor. Nat Rev Neurosci. 2005; 6(7):565-575.
16. Johansson T, Frändberg PA, Nyberg F, et al. Molecular mechanisms for nanomolar concentrations of neuroste-roids at NR1/NR2B receptors. J Pharmacol Exp Ther. 2008;324(2):759-768.
17. Belelli D, Herd MB, Mitchell EA, et al. Neuroactive steroids and inhibitory neurotransmission: mechanisms of action and physiological relevance. Neuroscience. 2006;138(3): 821-829.
18. Dubrovsky BO. Steroids, neuroactive steroids and neu-rosteroids in psychopathology. Prog Neuropsychophar-macol Biol Psychiatry. 2005;29(2):169-192.
19. Carroll JC, Rosario ER, Chang L, et al. Progesterone and estrogen regulate Alzheimer-like neuropathology in female 3xTg-AD mice. J Neurosci. 2007;27(48):13357-13365.
20. Mao X, Barger SW. Neuroprotection by dehydroepian-drosterone-sulfate: role of an NFkappaB-like factor. Neu-roreport. 1998;9(4):759-763.
21. Rosario ER, Chang L, Head EH, et al. Brain levels of sex steroid hormones in men and women during normal aging and in Alzheimer's disease. Neurobiol Aging. 2011;32(4): 604-613.
22. Luchetti S, Bossers K, Van de Bilt S, et al. Neurosteroid biosynthetic pathways changes in prefrontal cortex in Alzheimer's disease. Neurobiol Aging. 2011;32(11):1964-1976.
23. Yu Y, Xue G, Wu HH, et al. Effect of Aβ25-35 on neuroste-roidogenesis in primary rat cortical neurons. Zhongguo Yaoli Xue Tongbao. 2010;26(6):783-786.
24. Yu Y, Hou YN, Wu HH, et al. Effect of progesterone and allopregnanolone on cultured neurons exprosed to Aβ25-35. Zhongguo Yiyuan Yaoxue Zazhi. 2011(8):666-669.
25. Yu Y, Hou YN, Wu HH, et al. Effects of PROG treatment on neuronal apoptosis in Aβ25-35 induced AD model. Zhongguo Yaoli Xue Tongbao. 2011;27(8):1152-1156.
26. Mo L, Yang Z, Zhang A, et al. The repair of the injured adult rat hippocampus with NT-3-chitosan carriers. Bio-materials. 2010;31(8):2184-2192.
27. Aguado-Llera D, Martín-Martínez M, García-López MT, et al. Gly-Pro-Glu protects beta-amyloid-induced somatosta-tin depletion in the rat cortex. Neuroreport. 2004; 15(12):1979-1982.
28. Ruan CJ, Zhang L, Chen DH, et al. Effects of trans-2,4-dimethoxystibene against the neurotoxicity induced by Abeta(25-35) both in vitro and in vivo. Neurosci Res. 2010;67(3):209-214.
29. Cho SO, Ban JY, Kim JY, et al. Aralia cordata protects against amyloid beta protein (25-35)-induced neurotoxicity in cultured neurons and has antidementia activities in mice. J Pharmacol Sci. 2009;111(1):22-32.
30. Um MY, Choi WH, Aan JY, et al. Protective effect of Po-lygonum multiflorum Thunb on amyloid beta-peptide 25-35 induced cognitive deficits in mice. J Ethnopharma-col. 2006;104(1-2):144-148.
31. Huang HJ, Liang KC, Chen CP, et al. Intrahippocampal administration of A beta(1-40) impairs spatial learning and memory in hyperglycemic mice. Neurobiol Learn Mem. 2007;87(4):483-494.
32. Richwine AF, Parkin AO, Buchanan JB, et al. Architectural changes to CA1 pyramidal neurons in adult and aged mice after peripheral immune stimulation. Psychoneu-roendocrinology. 2008;33(10):1369-1377.
33. Mura E, Preda S, Govoni S, et al. Specific neuromodula-tory actions of amyloid-beta on dopamine release in rat nucleus accumbens and caudate putamen. J Alzheimers Dis. 2010;19(3):1041-1053.
34. Mura E, Zappettini S, Preda S, et al. Dual effect of be-ta-amyloid on α7 and α4β2 nicotinic receptors controlling the release of glutamate, aspartate and GABA in rat hip-pocampus. PLoS One. 2012;7(1):e29661.
35. Findeis MA. The role of amyloid beta peptide 42 in Alz-heimer's disease. Pharmacol Ther. 2007;116(2):266-286.
36. Smith JA, Das A, Ray SK, et al. Role of pro-inflammatory cytokines released from microglia in neurodegenerative diseases. Brain Res Bull. 2012;87(1):10-20.
37. Viel JJ, McManus DQ, Smith SS, et al. Age-and concen-tration-dependent neuroprotection and toxicity by TNF in cortical neurons from beta-amyloid. J Neurosci Res. 2001;64(5):454-465.
38. Rubio-Perez JM, Morillas-Ruiz JM. A review: inflammatory process in Alzheimer's disease, role of cytokines. Scien-tific World Journal. 2012;2012:756357.
39. Shaftel SS, Griffin WS, O'Banion MK. The role of inter-leukin-1 in neuroinflammation and Alzheimer disease: an evolving perspective. J Neuroinflammation. 2008;5:7.
40. Caruso D, Scurati S, Maschi O, et al. Evaluation of neu-roactive steroid levels by liquid chromatography-tandem mass spectrometry in central and peripheral nervous system: effect of diabetes. Neurochem Int. 2008;52(4-5): 560-568.
41. Serra M, Pisu MG, Littera M, et al. Social isolation-induced decreases in both the abundance of neuroactive steroids and GABA(A) receptor function in rat brain. J Neurochem. 2000;75(2):732-740.
42. Anderson GD, Farin FM, Bammler TK, et al. The effect of progesterone dose on gene expression after traumatic brain injury. J Neurotrauma. 2011;28(9):1827-1843.
43. Weill-Engerer S, David JP, Sazdovitch V, et al. Neuroste-roid quantification in human brain regions: comparison between Alzheimer's and nondemented patients. J Clin Endocrinol Metab. 2002;87(11):5138-5143.
44. Caruso D, Barron AM, Brown MA, et al. Age-related changes in neuroactive steroid levels in 3xTg-AD mice. Neurobiol Aging. 2013;34(4):1080-1089.
45. Yue X, Lu M, Lancaster T, et al. Brain estrogen deficiency accelerates Abeta plaque formation in an Alzheimer's disease animal model. Proc Natl Acad Sci U S A. 2005; 102(52):19198-19203.
46. Twist SJ, Taylor GA, Weddell A, et al. Brain oestradiol and testosterone levels in Alzheimer's disease. Neurosci Lett. 2000;286(1):1-4.
47. Kong M, Ba M. Protective effects of diazoxide against Aβ25-35-induced PC12 cell apoptosis due to prevention of endoplasmic reticulum stress. Neuroreport. 2012;23(8): 493-497.
48. Lewis MC, Orr PT, Frick KM. Differential effects of acute progesterone administration on spatial and object memory in middle-aged and aged female C57BL/6 mice. Horm Behav. 2008;54(3):455-462.
49. Bimonte-Nelson HA, Singleton RS, Williams BJ, et al. Ovarian hormones and cognition in the aged female rat: II. progesterone supplementation reverses the cognitive enhancing effects of ovariectomy. Behav Neurosci. 2004; 118(4):707-714.
50. Xu L, Sapolsky RM, Giffard RG. Differential sensitivity of murine astrocytes and neurons from different brain re-gions to injury. Exp Neurol. 2001;169(2):416-424.
51. Moorthy K, Yadav UC, Siddiqui MR, et al. Effect of hor-mone replacement therapy in normalizing age related neuronal markers in different age groups of naturally menopausal rats. Biogerontology. 2005;6(5):345-356.
52. Gibson CL, Constantin D, Prior MJ, et al. Progesterone suppresses the inflammatory response and nitric oxide synthase-2 expression following cerebral ischemia. Exp Neurol. 2005;193(2):522-530.
53. Escudero C, Casas S, Giuliani F, et al. Allopregnanolone prevents memory impairment: effect on mRNA expression and enzymatic activity of hippocampal 3-α hydroxysteroid oxide-reductase. Brain Res Bull. 2012;87(2-3):280-285.
54. Ishihara Y, Kawami T, Ishida A, et al. Allopregnanolone-mediated protective effects of progesterone on tributyl-tin-induced neuronal injury in rat hippocampal slices. J Steroid Biochem Mol Biol. 2013;135:1-6.
55. Mateos L, Persson T, Katoozi S, et al. Estrogen protects against amyloid-β toxicity by estrogen receptor α-mediated inhibition of Daxx translocation. Neurosci Lett. 2012;506(2):245-250.
56. Simpkins JW, Yi KD, Yang SH, et al. Mitochondrial me-chanisms of estrogen neuroprotection. Biochim Biophys Acta. 2010;1800(10):1113-1120.
57. The Ministry of Science and Technology of the People's Republic of China. Guidance Suggestions for the Care and Use of Laboratory Animals. 2006-09-30.